GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (OTCPK:SEOVF) » Definitions » Net Margin %

SEOVF (Sernova Biotherapeutics) Net Margin % : 0.00% (As of Jan. 2025)


View and export this data going back to 1998. Start your Free Trial

What is Sernova Biotherapeutics Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Sernova Biotherapeutics's Net Income for the three months ended in Jan. 2025 was $-3.96 Mil. Sernova Biotherapeutics's Revenue for the three months ended in Jan. 2025 was $0.00 Mil. Therefore, Sernova Biotherapeutics's net margin for the quarter that ended in Jan. 2025 was 0.00%.

The historical rank and industry rank for Sernova Biotherapeutics's Net Margin % or its related term are showing as below:


SEOVF's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -132.42
* Ranked among companies with meaningful Net Margin % only.

Sernova Biotherapeutics Net Margin % Historical Data

The historical data trend for Sernova Biotherapeutics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Biotherapeutics Net Margin % Chart

Sernova Biotherapeutics Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sernova Biotherapeutics Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sernova Biotherapeutics's Net Margin %

For the Biotechnology subindustry, Sernova Biotherapeutics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sernova Biotherapeutics's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Sernova Biotherapeutics's Net Margin % falls into.


;
;

Sernova Biotherapeutics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Sernova Biotherapeutics's Net Margin for the fiscal year that ended in Oct. 2024 is calculated as

Net Margin=Net Income (A: Oct. 2024 )/Revenue (A: Oct. 2024 )
=-23.4/0
= %

Sernova Biotherapeutics's Net Margin for the quarter that ended in Jan. 2025 is calculated as

Net Margin=Net Income (Q: Jan. 2025 )/Revenue (Q: Jan. 2025 )
=-3.958/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sernova Biotherapeutics  (OTCPK:SEOVF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Sernova Biotherapeutics Net Margin % Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sernova Biotherapeutics Business Description

Traded in Other Exchanges
Address
700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8
Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.